LEADER 02141nas  2200637-a 450 
001 996520272603316
005 20240319193327.0
011   $a1525-6006
035   $a(DE-599)ZDB2026245-0
035   $a(OCoLC)41602417
035   $a(CKB)954925600660
035   $a(CONSER)sn-99004079-
035   $a(EXLCZ)99954925600660
100   $a19990624a19939999  s--         a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aClinical and experimental hypertension
210   $aNew York, NY $cMarcel Dekker, Inc
210 3 $a[Philadelphia, PA] $cTaylor & Francis Group
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aClinical and Experimental Hypertension converted to a full Open Access journal from Volume 45 (2023). Previous volumes will continue to provide access through a Pay to Read model.
311   $a1064-1963 
531   $aCLIN EXP HYPERTENSION
531   $aCLIN EXP HYPERTENS
531   $aCLIN EXP HY
531   $aCLIN. EXP. HYPERTENS
531 0 $aClin. exp. hypertens.
606   $aHypertension$xChemotherapy$vPeriodicals
606   $aHypotensive agents$vPeriodicals
606   $aHypertension artérielle$xChimiothérapie$vPériodiques
606   $aHypotenseurs$vPériodiques
606   $aCardiology$2ebps
606   $aVascular Medicine$2ebps
606   $aHypertension$xChemotherapy$2fast$3(OCoLC)fst00965835
606   $aHypotensive agents$2fast$3(OCoLC)fst00966065
608   $aPeriodical
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
608   $aPériodiques.$2rvmgf
615  0$aHypertension$xChemotherapy
615  0$aHypotensive agents
615  6$aHypertension artérielle$xChimiothérapie
615  6$aHypotenseurs
615  7$aCardiology.
615  7$aVascular Medicine.
615  7$aHypertension$xChemotherapy.
615  7$aHypotensive agents.
676   $a616
906   $aJOURNAL
912   $a996520272603316
996   $aClinical and experimental hypertension$92437033
997   $aUNISA